SUMMARY Choline levels in lumbar cerebrospinal fluid (CSF) were measured in patients with craniocerebral trauma (N = 67), Parkinson's disease (N = 20), miscellaneous extrapyramidal disorders (N = 28) and Huntington's chorea (N = 5). No differences in CSF choline levels were observed between these diagnostic groups and a group of neurological controls (N = 22). However, CSF choline levels were found to increase with age.
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From studies on choline metabolism in rabbits it appears that 42% of CSF choline originates from plasma choline and the remaining part from plasma or brain phospholipids, while no contribution from acetylcholine metabolism in the brain could be detected.' 2 Reported findings of normal CSF choline levels in Parkinson's disease,34 Huntington's chorea45 and Alzheimer s disease6 ' suggest that also in humans impaired central cholinergic activity is not reflected in the CSF choline levels. Part of the present study is an attempt to confirm these findings in Parkinson's disease and Huntington's chorea.
Accepting the view that CSF choline levels are largely determined by blood choline levels and by choline derived from the breakdown of phospholipids in the brain, we might expect to find abnormal CSF choline levels in those diseases in which disturbances of the blood-brain barrier or of brain phospholipid metabolism may occur. We therefore measured also CSF choline levels in patients with cranial trauma in whom the bloodbrain barrier may be disturbed,8 and in patients with extrapyramidal disorders in whom degenerative processes might be assumed. 14 controls and six Parkinsonian patients it was possible to obtain also an aliquot of the second 10 ml fraction of CSF. The samples were immediately frozen after collection and kept at -20°C until analysed. No special dietary precautions were taken, the patients receiving normal hospital diets containing an estimated amount of 250-600 mg choline/24 h.
The patients were divided in three main groups.
(1) Controls. This group consisted of 22 individuals, who were admitted for myelography on suspicion of a herniated disk.
(2) Cranial trauma. This group consisted of 67 patients who were admitted following cranial trauma, most of whom suffered from severe concussion; three patients had a subdural or epidural haematoma and two patients had post-traumatic complaints. Spinal taps were performed respectively between 1 and 14 days (n = 43), between 15 and 28 days (n = 12), and between 29 and 90 days (n = 10) following the accident. In the two patients with post-traumatic complaints CSF was obtained respectively 2 and 7 years after the accident.
(3) Extrapyramidal disorders. This group comprised patients suffering from so-called extrapyramidal disorders.
At the time of collection of CSF the patients were admitted for clinical evaluation and commonly did not receive any treatment, with a few exceptions. In the Gilles de la Tourette patients and in four of the five patients with Huntington's chorea the haloperidol medication was continued. It was common practice to discontinue anti-Parkinsonism medication before admission, but in four cases orphenadrine therapy was continued. 
Results
Nearly identical choline levels were found in two consecutive 10 ml fractions of lumbar CSF of both a group of 14 controls (mean + SD resp. 2.21 + 0*54 and 2*17 + 0.58 nmoles/ml) and a group of six Parkinson patients (resp. 2X24 + 0X28 and 2X20 + 0X29 nmoles/ml). The table shows that no large differences in CSF choline levels were found between the investigated groups. However, it can be seen that the sex and age distribution over the groups is quite dissimilar. Therefore, the differences between the patient groups and the control group were tested by analysis of covariance with sex and age as covariates and diagnosis as the main effect. Due to the small number the group of patients with Huntington's chorea was excluded from this analysis, but this group was found not to differ from the control group by Student's t test (p > 0-05). The analysis of covariance showed that no significant differences in CSF choline levels were detected between the control group and any of the patient groups we investigated. It was also found that CSF choline levels were 4 In support of this, we measured high choline levels in ventricular CSF obtained from one patient with essential tremor and one with Parkinson's disease (respectively 3-84 and 3*45 nmoles/ml).
It has been reported by Glen et al7 that in a group of 35 neurological controls CSF choline increased significantly with age. In this paper we have shown that CSF choline levels are related to age in the control group as well as in the cranial trauma group, the group with miscellaneous extrapyramidal disorders and the Parkinson's disease group. As the increase per year was not significantly different for these groups, we were able to calculate that for the combined groups choline levels in lumbar CSF can be described by the formula: CSF choline (nmoles/ ml) = 1*59 + 0*016 x age (in years). This formula indicates that in comparing CSF choline levels of different groups it is necessary to correct for differences in age, which we did by introducing age as a covariate in the analysis of covariance.
Our finding that CSF choline levels of the control group was not different from those in the Parkinson group confirms earlier reports.3 4 Also, the unchanged CSF choline levels we found in Huntington's chorea are in agreement with the results of Welch et a14 and Growdon et al,S but contrast with an early report of Aquilonius et al.3 In this connection it is interesting that unchanged 
